DK0443413T3 - Farmaceutisk præparat med afpigmenterende virkning og antifotoældningsvirkning - Google Patents

Farmaceutisk præparat med afpigmenterende virkning og antifotoældningsvirkning

Info

Publication number
DK0443413T3
DK0443413T3 DK91101930.5T DK91101930T DK0443413T3 DK 0443413 T3 DK0443413 T3 DK 0443413T3 DK 91101930 T DK91101930 T DK 91101930T DK 0443413 T3 DK0443413 T3 DK 0443413T3
Authority
DK
Denmark
Prior art keywords
combination
effect
azelaic
pigmenting
retinoic
Prior art date
Application number
DK91101930.5T
Other languages
English (en)
Inventor
Ruggero Caputo
Original Assignee
Schering Spa
Cilag Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Spa, Cilag Spa filed Critical Schering Spa
Application granted granted Critical
Publication of DK0443413T3 publication Critical patent/DK0443413T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
DK91101930.5T 1990-02-20 1991-02-12 Farmaceutisk præparat med afpigmenterende virkning og antifotoældningsvirkning DK0443413T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT01942290A IT1242478B (it) 1990-02-20 1990-02-20 Composizioni farmaceutiche ad attivita' depigmentante e contro il danneggiamento cutaneo fotoindotto.

Publications (1)

Publication Number Publication Date
DK0443413T3 true DK0443413T3 (da) 1994-07-25

Family

ID=11157744

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91101930.5T DK0443413T3 (da) 1990-02-20 1991-02-12 Farmaceutisk præparat med afpigmenterende virkning og antifotoældningsvirkning

Country Status (14)

Country Link
EP (1) EP0443413B1 (da)
JP (1) JPH08239320A (da)
KR (1) KR910021235A (da)
AT (1) ATE104144T1 (da)
AU (1) AU7118091A (da)
CA (1) CA2036678A1 (da)
DE (1) DE69101651T2 (da)
DK (1) DK0443413T3 (da)
IE (1) IE910558A1 (da)
IL (1) IL97271A0 (da)
IT (1) IT1242478B (da)
NZ (1) NZ237137A (da)
PT (1) PT96814B (da)
ZA (1) ZA911222B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547989A (en) * 1994-08-19 1996-08-20 Schering-Plough Healthcare Products, Inc. Compositions for treating corns and calluses
US20050226899A1 (en) * 2004-04-08 2005-10-13 Mauro Castiglioni Cosmetic mask composition
DE102006004804A1 (de) 2006-01-23 2007-07-26 Intendis Gmbh Verwendung von Alkandicarbonsäuren und Retinoiden zur Behandlung entzündlicher Hauterkrankungen
US20100273756A1 (en) * 2009-04-27 2010-10-28 Reza Babapour Adjunctive formulation and methods for palliation of fine wrinkles, mottled hyperpigmentation, tactile roughness of facial skin and related disorders
WO2012053009A2 (en) * 2010-10-21 2012-04-26 Cadila Healthcare Limited Pharmaceutical compositions comprising skin whitening agents
EP3359147B1 (en) 2015-07-30 2023-05-03 Curology, Inc. Compositions amd methods of treating acne and photoaging

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
DE3623862A1 (de) * 1986-07-11 1988-01-21 Schering Ag Verwendung von dicarbonsaeuren mit 7 - 13 kohlenstoffatomen oder physiologisch vertraeglichen salzen davon zur topischen behandlung von rosazea
JP2565513B2 (ja) * 1987-09-25 1996-12-18 三省製薬株式会社 メラニン生成抑制外用薬剤

Also Published As

Publication number Publication date
KR910021235A (ko) 1991-12-20
ZA911222B (en) 1991-11-27
JPH08239320A (ja) 1996-09-17
PT96814B (pt) 1998-07-31
EP0443413A1 (en) 1991-08-28
IL97271A0 (en) 1992-05-25
IT9019422A1 (it) 1991-08-21
NZ237137A (en) 1992-04-28
ATE104144T1 (de) 1994-04-15
IT1242478B (it) 1994-03-17
PT96814A (pt) 1991-10-31
DE69101651D1 (de) 1994-05-19
CA2036678A1 (en) 1991-08-21
DE69101651T2 (de) 1994-08-11
IT9019422A0 (it) 1990-02-20
EP0443413B1 (en) 1994-04-13
AU7118091A (en) 1991-08-22
IE910558A1 (en) 1991-08-28

Similar Documents

Publication Publication Date Title
ATE89723T1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
DE3263057D1 (en) Hair treatment compositions
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
ATE97805T1 (de) Zusammensetzung und verfahren zur behandlung von erkrankungen.
DE68909077T2 (de) Gamma-Linolensäure oder Dihomo-gamma-Linolensäure enthaltende Zubereitung zur Verbesserung der Haut.
DE122007000080I1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzündlicher und viraler hauterkrankungen.
ATE178616T1 (de) Verfahren zur herstellung von biologisch aktivem protein (z.b. tgf)
EP0053448A3 (en) Pre-shampoo type hair treatment composition
ATE149833T1 (de) Verwendung von amino-2-trifluormethoxy-6- benzothiazol (riluzol) zur herstellung eines medikamentes zur behandlung von erkrankungen des motoneurons
EP0250994A3 (en) Product for covering healthy or damaged areas of the human or animal skin
IT1105040B (it) 3-1h-tetrazol-5-il-4h-pirido 1,2-a pirimidin-4-oni sostituiti utili in particolare come agenti terapeutici per inibire le reazioni allergiche e procedimento per la produzione dei detti derivati
ATE145136T1 (de) Verwendung von ketoconazol und ein retinoid zur behandlung der akne vulgaris
DE59303365D1 (de) Derivate in der vitamin d-reihe mit modifikationen in der 20 position, verfahren zu ihrer herstellung, zwischenprodukte für dieses verfahren, diese derivate enthaltende pharmazeutische präparate sowie deren verwendung zur herstellung von arzneimitteln
FI103506B1 (fi) Menetelmä syklisten aminohappojohdannaisten valmistamiseksi ja menetelmässä käytettävä välituote
ATE114412T1 (de) Verwendung eines pyrodextrinhydrolysates zur herstellung einer nahrungsmittelzusammensetzung zur verbesserung der serumlipidzusammensetzung.
DE3583220D1 (de) Verwendung von dipeptidderivaten fuer die herstellung von arzneimitteln zur behandlung von an amyotropher lateralsklerose erkrankten.
DK0443413T3 (da) Farmaceutisk præparat med afpigmenterende virkning og antifotoældningsvirkning
CA2326148A1 (en) Method for providing glutamine
NO175885C (no) Fremgangsmåte for fremstilling av et salicylsyreholdig middel for lokal behandling av hudsykdommer med avskalling
ES2047674T3 (es) Composicion cosmetica.
DE69003960T2 (de) Die Verwendung von deacetyliertem Chitin zur Herstellung eines Medikamentes für die Behandlung von entzündliche Krankheiten.
ATE102824T1 (de) Verwendung von retinoiden zur verhinderung und verkleinerung von dehnungsstreifen.
ATE143809T1 (de) Placentaextrakt und verfahren zu seiner herstellung
ATE122563T1 (de) Verwendung von 15-keto-prostansäure-derivaten zur herstellung eines medikaments für die verbesserung der ausscheidung des kaliumions.
ATE116544T1 (de) Zusammensetzung und verwendung dieser zusammensetzung zur herstellung eines arzneimittels für die behandlung von durch wärme- und lichtstrahlung verursachten verletzungen.